MedPath
NMPA Approval

Fluticasone Propionate Inhalation Aerosol

国药准字HJ20130189

December 27, 2023

H20130189

Drug Information

丙酸氟替卡松吸入气雾剂

辅舒酮

吸入气雾剂

每瓶120揿,每揿含丙酸氟替卡松50μg,递送剂量为丙酸氟替卡松44μg

化学药品

December 27, 2023

October 15, 2028

Company Information

Applicant Company

GLAXOSMITHKLINE SA

Severo Ochoa, 2, 28760 Tres Cantos (Madrid), Spain

Manufacturing Company

Glaxo Wellcome SA

Avda de Extremadura 3 Poligono Industrial Allenduero Aranda De Duero, Burgos, 09400 Spain

© Copyright 2025. All Rights Reserved by MedPath
丙酸氟替卡松吸入气雾剂 - NMPA 批准文号 | MedPath